423 related articles for article (PubMed ID: 34880867)
1. Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines.
Zhang Y; Banga Ndzouboukou JL; Gan M; Lin X; Fan X
Front Immunol; 2021; 12():771242. PubMed ID: 34880867
[TBL] [Abstract][Full Text] [Related]
2. Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines.
Yang Y; Zang J; Xu S; Zhang X; Yuan S; Wang H; Lavillette D; Zhang C; Huang Z
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452287
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Variants, Vaccines, and Host Immunity.
Mistry P; Barmania F; Mellet J; Peta K; Strydom A; Viljoen IM; James W; Gordon S; Pepper MS
Front Immunol; 2021; 12():809244. PubMed ID: 35046961
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants.
Rotondo JC; Martini F; Maritati M; Mazziotta C; Di Mauro G; Lanzillotti C; Barp N; Gallerani A; Tognon M; Contini C
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578269
[TBL] [Abstract][Full Text] [Related]
5. Omicron: Call for updated vaccines.
Li X
J Med Virol; 2022 Apr; 94(4):1261-1263. PubMed ID: 34927258
[TBL] [Abstract][Full Text] [Related]
6. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.
Wang P; Nair MS; Liu L; Iketani S; Luo Y; Guo Y; Wang M; Yu J; Zhang B; Kwong PD; Graham BS; Mascola JR; Chang JY; Yin MT; Sobieszczyk M; Kyratsous CA; Shapiro L; Sheng Z; Huang Y; Ho DD
Nature; 2021 May; 593(7857):130-135. PubMed ID: 33684923
[TBL] [Abstract][Full Text] [Related]
7. Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies.
Bian L; Gao F; Zhang J; He Q; Mao Q; Xu M; Liang Z
Expert Rev Vaccines; 2021 Apr; 20(4):365-373. PubMed ID: 33851875
[TBL] [Abstract][Full Text] [Related]
8. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
9. Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections.
Ahmad L
Front Immunol; 2021; 12():742167. PubMed ID: 34804022
[TBL] [Abstract][Full Text] [Related]
10. Evolution of SARS-CoV-2: A prediction on the lineages and vaccine effectiveness.
Priyanka ; Choudhary OP; Singh I
Travel Med Infect Dis; 2021; 40():101983. PubMed ID: 33548551
[No Abstract] [Full Text] [Related]
11. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.
Gong W; Parkkila S; Wu X; Aspatwar A
Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216
[TBL] [Abstract][Full Text] [Related]
12. Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity.
Mengist HM; Kombe Kombe AJ; Mekonnen D; Abebaw A; Getachew M; Jin T
Semin Immunol; 2021 Jun; 55():101533. PubMed ID: 34836774
[TBL] [Abstract][Full Text] [Related]
13. Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges.
Abdullahi IN; Emeribe AU; Adekola HA; Abubakar SD; Dangana A; Shuwa HA; Nwoba ST; Mustapha JO; Haruna MT; Olowookere KA; Animasaun OS; Ugwu CE; Onoja SO; Gadama AS; Mohammed M; Daneji IM; Amadu DO; Ghamba PE; Onukegbe NB; Shehu MS; Isomah C; Babayo A; Ahmad AE
Hum Vaccin Immunother; 2021 Mar; 17(3):620-637. PubMed ID: 32936732
[TBL] [Abstract][Full Text] [Related]
14. The challenge of emerging SARS-CoV-2 mutants to vaccine development.
Li R; Liu J; Zhang H
J Genet Genomics; 2021 Feb; 48(2):102-106. PubMed ID: 33994322
[No Abstract] [Full Text] [Related]
15. SARS-CoV-2: Unique Challenges of the Virus and Vaccines.
Mahmoodpoor A; Sanaie S; Samadi P; Yousefi M; Nader ND
Immunol Invest; 2021 Oct; 50(7):802-809. PubMed ID: 34109900
[TBL] [Abstract][Full Text] [Related]
16. DNA vaccines against COVID-19: Perspectives and challenges.
Silveira MM; Moreira GMSG; Mendonça M
Life Sci; 2021 Feb; 267():118919. PubMed ID: 33352173
[TBL] [Abstract][Full Text] [Related]
17. The conundrum of current anti-SARS-CoV-2 vaccines.
Federico M
Cytokine Growth Factor Rev; 2021 Aug; 60():46-51. PubMed ID: 33714693
[TBL] [Abstract][Full Text] [Related]
18. Relevance of immune response and vaccination strategies of SARS-CoV-2 in the phase of viral red queen dynamics.
Jacob JJ; John Fletcher G; Monisha Priya T; Veeraraghavan B; Mutreja A
Indian J Med Microbiol; 2021; 39(4):417-422. PubMed ID: 34454775
[TBL] [Abstract][Full Text] [Related]
19. Humoral and cellular immunity against diverse SARS-CoV-2 variants.
Chen C; Wang X; Zhang Z
J Genet Genomics; 2023 Dec; 50(12):934-947. PubMed ID: 37865193
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 vaccines: a triumph of science and collaboration.
Golob JL; Lugogo N; Lauring AS; Lok AS
JCI Insight; 2021 May; 6(9):. PubMed ID: 33822773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
